398 results on '"Thivolet, Charles"'
Search Results
2. Impacts des évolutions technologiques sur la gestion des repas au cours du diabète de type 1
3. Actualisation de la prise de position des experts français sur l’insulinothérapie automatisée en boucle fermée
4. Development and validation of a Type 1 and Type 2 diabetes-specific patient-reported experience measure e-questionnaire: Diabetes reported experience measures (DREMS)
5. Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative
6. Dépistage et prise en charge du diabète de type 1 préclinique, stade 1–2. Prise de position d’experts français
7. Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study
8. Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study
9. Hope, hype and present limitations of hybrid closed loop systems for persons with type 1 diabetes
10. Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL network
11. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
12. Human Pancreatic Islets React to Glucolipotoxicity by Secreting Pyruvate and Citrate
13. Development and Validation of a Type 1 and Type 2 Diabetes-Specific Patient-Reported Experience Measure e-questionnaire: Diabetes Reported Experience MeasureS (DREMS)
14. Correction to: Cost-Effectiveness Evaluation of a Remote Monitoring Programme Including Lifestyle Education Software in Type 2 Diabetes: Results of the Educ@dom Study
15. The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
16. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
17. Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics.
18. Beneficial effects of automated insulin delivery over one‐year follow‐up in real life for youths and adults with type 1 diabetes irrespective of patient characteristics
19. Performance and patients’ satisfaction with the A7+TouchCare insulin patch pump system: A randomized controlled non-inferiority study
20. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial
21. Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide
22. Diabetes mellitus induced by PD-1 and PD-L1 inhibitors: description of pancreatic endocrine and exocrine phenotype
23. Usefulness of a systematic screening of carotid atherosclerosis in asymptomatic people with type 2 diabetes for cardiovascular risk reclassification
24. Twelve‐month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed‐loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.
25. Twelve-month results of the ADAPT randomized controlled trial: reproducibility and sustainability of advanced hybrid closed loop therapy outcomes versus conventional therapy in adults with type 1 diabetes
26. Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial
27. Télésuivi et téléaccompagnement du diabète : du programme expérimental ÉTAPES à la pratique clinique
28. A Cholera Toxoid-Insulin Conjugate as an Oral Vaccine against Spontaneous Autoimmune Diabetes
29. Carotid atherosclerosis progression and cerebrovascular events in patients with diabetes
30. Performance of the 4-mg intravenous dexamethasone suppression test in differentiating Cushing disease from pseudo-Cushing syndrome
31. Reduction of clinically important low glucose excursions with a long‐term implantable continuous glucose monitoring system in adults with type 1 diabetes prone to hypoglycaemia: the France Adoption Randomized Clinical Trial
32. Évaluer le ressenti des hypoglycémies chez des personnes vivant avec un diabète de type 1 reste toujours nécessaire en pratique clinique
33. Évaluer le ressenti des hypoglycémies chez des personnes vivant avec un diabète de type 1 reste toujours nécessaire en pratique clinique
34. EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?
35. Ascertaining the Utility of the Glycemia Risk Index for Glucose Outcomes With Hybrid Closed-Loop Therapy in Adolescents and Adults With Type 1 Diabetes.
36. Real-life Use of a Digital Health Support Solution in Patients Treated with Insulin in France. Usability Study (Preprint)
37. Fulminant diabetes induced by PD-1 and PD-L1 inhibitors: what about glucose variability?
38. Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response
39. 1492-PUB: In Silico Modeling of the Performance of a Novel Closed-Loop Algorithm Using the UVA/PADOVA Type 1 Diabetes Simulator
40. Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216–224.
41. Prise de position de la Société francophone du diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2 - 2021
42. Prise de position de la Société francophone du diabète (SFD) sur les stratégies d’utilisation des traitements anti-hyperglycémiants dans le diabète de type 2–2021
43. Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
44. Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network
45. Author response for 'No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed-loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial'
46. Human Monoclonal Islet Cell Antibodies From a Patient with Insulin- Dependent Diabetes Mellitus Reveal Glutamate Decarboxylase as the Target Antigen
47. No more hypoglycaemia on days with physical activity and unrestricted diet when using a closed‐loop system for 12 weeks: A post hoc secondary analysis of the multicentre, randomized controlled Diabeloop WP7 trial
48. Télésurveillance et diabète. Prise de position de la Société francophone du diabète (SFD). En collaboration avec la Société française d’endocrinologie et diabétologie pédiatrique (SFEDP), le Conseil national professionnel d’endocrinologie, diabétologie et nutrition (CNPEDN), la Fédération française des diabétiques (FFD) et l’Aide aux jeunes diabétiques (AJD)
49. Influenza vaccination and prognosis of COVID ‐19 in hospitalized patients with diabetes: Results from the CORONADO study
50. Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.